The calculated fraction of receptor ligands avail able for blood-brain barrier passage in vivo (favail) may differ from in vitro (fe q ) measurements. This study evaluates the pro tein-ligand interaction for iomazenil and flumazenil in rats by comparing fe q and favail' Repeated measurements of blood brain barrier permeability for two benzodiazepine antagonists were performed in 44 rats by the double-indicator technique. Cerebral blood flow was measured by intracarotid Xe-injection.
by equilibrium dialysis. Iomazenil and flumazenil favail was 62% and 82%, respectively, whereas fe q was significantly lower, 42% and 61 %. The PSapp for iomazenil and flumazenil increased significantly by 89% and 161% after relative CBF increases of 259% and 201 %, respectively. The results demon strate that application of fe q in neuroreceptor studies underes timates the plasma input function to the brain. Model simula tions render possible that the differences between favai l and fe q as well as the effect of CBF on PSapp can be caused by capillary heterogeneity. Key Words: Capillary heterogeneity-Recruit ment-Iomazenil-Flumazenil-Protein-ligand interaction.
across the blood-brain barrier (BBB). The free fraction of the ligand, as measured by equilibrium dialysis or ultra filtration (fe q ), has previously been assumed to represent the fraction available for BBB transport. However, it remains to be established whether the free fraction of ligands as measured in vitro corresponds to in vivo de terminations. It has been shown in in vivo studies that the brain uptake of plasma protein-bound substances (Jones et aI., 1988; Pardridge and Fierer, 1990) is higher than what could be expected from the in vitro measured fe q .
Similar findings have been reported in studies of the liver (Forker et aI., 1985; Keiding, 1993) and of isolated adi pocytes and cardiac myocytes (Sorrentino et aI., 1989) .
This has been interpreted as an accelerated dissociation of ligand from the plasma protein in the capillary bed (Pardridge and Fierer, 1990) . Notice that even if the li gand-protein dissociation is instantaneous and the brain uptake extremely high, the difference between in vitro and in vivo studies is not explained, since the plasma water ligand concentration will never exceed that of the equilibrium concentration. If, on the other hand, the dis sociation of the plasma protein-ligand complex is so slow that this process becomes the rate-limiting step for brain uptake, a nonequilibrium condition may arise in the capillary (Robinson and Rapoport, 1986; Weisiger, 1985) . In this condition, the mean capillary transit time (or CBF as a determinant of this) may play a role, whereas the difference between in vitro and in vivo stud ies remain unexplained. By contrast, the brain uptake then would become smaller than predicted, since the plasma water ligand concentration would drop below the equilibrium concentration.
Previous models addressing this problem (Pardridge and Fierer, 1990 ; Robinson and Rapoport, 1986; Weisiger, 1985; Weisiger et aI., 1991) , however, all as sume that brain capillaries are homogeneous and ar ranged functionally in parallel so that they share the same inlet and outlet concentrations. As is shown later, violation of this assumption, here termed capilla/}' het erogeneity, invalidates predictions from the Bohr-Kety Renkin-Crone equation (Bass, 1983) . This study ad dresses the relevance of the in vitro-determined free fraction of ligands for the benzodiazepine receptor sys tem as well as the brain uptake dependency of changes in the capillary transit time. We determined the apparent in vivo fraction available for BBB transport ( fa v a il) in rats for two benzodiazepine receptor ligands, [ 125 I]iomazenil
and eH]flumazenil, by comparing brain uptake in the presence and absence of 5% albumin. The influence of changes in mean qlpillary transit time on cerebral ligand uptake was evaluated by inducing changes in CBF.
METHODS

Materials and surgery
Forty-four male Wi star rats with a body weight between 320 and 370 g were studied. The experiments were approved by the local authorities. Anesthesia was initiated by 4% halothane. After tracheostomy had been performed, anesthesia was main tained with 0.7% halothane in a gas mixture of 70% N2 and 30% O2, The animals were artificially ventilated by a Harvard Miniature animal ventilator (Edenbridge, KY, U.S.A.) and were immobilized by intravenous injections of 40 mg/kg suc cinyl choline every hour. An adequate level of anesthesia was monitored continuously throughout the study by blood pressure and heart rate measurements that remained stable also under noxious stimuli. Both femoral arteries were cannulated for re cording of blood pressure, heart rate and blood gases (pH, Pc02, P02). A femoral vein was cannulated for blood transfusions to replace blood loss and for succinyl choline injection. Replace ment blood was obtained from naive rats, typically 0.2 mL per CBF measurement and 0.4 mL per double indicator run. Rectal temperature was continuously monitored and kept close to 37°C by a thermostat-controlled heated table.
Skin and muscles of the scalp were deflected. On the right side of the neck, the carotid bifurcation was exposed, and the external carotid artery was ligated. All major extracerebral branches from the carotid artery, including the pterygopalatine artery, were ligated. These extensive ligations ensure that blood from the extracranial tissues draining into the sagittal sinus does not contribute to the outflow curves (Hertz and Bolwig, 1976) . A polyethylene catheter was placed in the external ca rotid artery with the tip at the carotid bifurcation so that flow obstruction of the right internal carotid artery was avoided. The animals were heparinized by 1000 IE intravenously, and all wounds were infiltrated with lidocaine I %. After 30 minutes' rest, a hole was drilled in the skull, and a blunt sawn-off 18-gauge needle was placed in the confluence sinus for cerebral venous blood sampling. Blood gases were analyzed by means of an ABL 30 (Radiometer, Copenhagen, Denmark).
Measurement of cerebral blood flow
Cerebral blood flow was measured twice to establish base line values. Subsequently, CBF measurements were performed at least once every hour or at Pco2 changes larger than I mm Hg. A 20-f-LL bolus of the radioactive inert gas [ 133 Xe] dis solved in saline was injected into the carotid artery, and the brain clearance curve was recorded by a collimated NaI crystal placed over the ipsilateral hemisphere. The CBF was calculated from the initial monoexponentiel part of the clearance curve (Olesen et a!., 1971) . The CBF was increased by adding ap proximately 6% CO2 to the inhaled gas mixture and decreased by hyperventilation. No animals were exposed to both situa tions.
Blood-Brain barrier measurements
Between 4 and 10 BBB measurements were performed in each animal, and at least once it was checked that significant extracranial contamination did not take place. In extracranial tissues, e 6 Cl] and [ 2 4 Nal have an extraction of about 50%, whereas the extraction in brain tissue is only I % to 2% (Hertz and Bolwig, 1976 A.) , was rapidly injected into the carotid artery just after blood sampling from the cerebral venous sinus was started. Twelve cerebral venous blood samples, approxi mately one sample per second, were collected from the needle placed in the cont1uence sinus. The blood was allowed to drip into the vials so that suction from the venous sinus was avoided. For normalization of outflow curves, an aliquot of injectate was mixed with saline and analyzed with the blood samples. All samples were bleached by H202 to decrease quenching. To evaluate bolus mixing with blood during the capillary passage, the size of the saline bolus was altered between 20 and 120IJ.L Since iomazenil and flumazenil are rapidly metabolized in plasma by esterase, either plasma esterase-inactivated (NaF heparin) plasma or 5% albumin had to be used in the prepara tion of the injectate. Since the effect on the BBB of repeated NaF exposures is unknown, a 5% albumin solution was pre ferred. In eight animals it was, however, ensured that brain uptake was similar, whether a bolus with NaF-treated plasma or 5% albumin was used.
In BBB experiments where CBF changes had been induced, a 5% albumin bolus was used. U.S.A.) with subsequent spillover and decay correction. When e 6 CI] was used as a reference, 10 mL of scintillation fluid (Ultima Gold, Packard Instrument, Groningen, Holland) was added to the vial, which then was counted in a )I-counter (Pack ard 1900 CA, Canberra Packard) with subsequent spillover and quench correction.
Calculation of blood-brain barrier permeability
The brain extraction at time t [E(t)] was calculated from
where C re tCt) and Ctest(t) are the normalized sample concentra tions of reference and test substance at time t. The extraction at the peak of the outflow curve (E) usually is considered the most correct measure of unidirectional brain extraction (Paulson and Hertz, 1983) . To evaluate tracer backflux, the extraction cal culated from the total time course (approximately 10 seconds) was calculated and compared with E. The permeability-surface product (PSa pp ) was calculated ac cording to the Bohr-Kety-Renkin-Crone equation:
This equation was derived for a single cylindrical capillary within which a fluid of uniform composition flows at a constant velocity.
Calculation.:of favail
If it is assumed that the brain capillary bed is homogeneous and the ligand is not protein bound, PSa pp (Eq. 2) equals PS defined as the sum of individual capillary PS values. For pro tein-bound ligands, PSa pp equals PS . fa v ail (Pardridge, 1983) , thus
Measurements of f e g were performed in vitro by equilibrium dialysis using a Kontron Diapack model 4000 with a cellulose membrane (Sigma, St. Louis, MO, U.S.A.), which retains pro teins with a molecular weight larger than 12,000. The molecu lar weight of iomazenil and flumazenil is 409 and 305, respec tively. To evaluate the effect of binding proteins other than albumin, [ 1 2 5 I]iomazenil was added to NaF-heparinized plasma samples from eight Wistar male rats and to eight samples of 5% human albumin, whereas [ 3 HJflumazenil was added to eight samples of human albumin. A mixture of plasma and 5% hu man albumin (1.5 mL) was dialyzed at 37°C for 4 hours when e 2 5 I]iomazenil was added and for 24 hours when eH]fluma zenil was added, against an equal volume of isotonic phosphate buffer (pH 7.4). Subsequently, 50 ILL was taken from both compartments. Two milliliters of Pico-Flour (Packard Instru ment) were added to vials with flumazenil and counted in a Hewlett Packard 1900 CA j3-counter with subsequent quench correction. Vials containing iomazenil were counted in a Cobra 5002/5003 )I-counter. The f eq was calculated as the cpm ratio between buffer and plasma.
Assuming tracer concentrations of the ligand, the dissocia tion constant, Kd, was estimated for both ligands according to Eq. 4, where Cal b is the albumin concentration in the sample (725 ILmoI/L).
The calculated Kd values were used for the computer simu lations as presented in the appendix.
Simulation models
To evaluate the potential influence of nonequilibrium con ditions, unstirred water layer effects and capillary heterogeneity simulation models were applied, and the results were compared with the observed data. These simulations are described in the appendix.
Statistics
Results are presented as median values with quartiles in brackets. The Wilcoxon paired nonparametric test was used for comparison of CBF, extraction, and PSa p /f eq . The Mann Whitney test was used to compare the in vivo measured avail able fraction for BBB transport and in vitro measured free fractions. A significance level of 0.05 was chosen.
RESULTS
Iomazenil
There was no difference in fe q for iomazenil as mea sured in plasma compared with measurements in 5% human albumin where fe q was 42%.
An example of a venous outflow curve for [ 1 2 5 I]ioma_ zenil with its corresponding extraction curve is shown in Fig. 1 . No difference between peak and the total extrac tion was found. Values for CBF, extraction, and PSa pp for the paired observations are presented in Table 1 . In the presence of 5% albumin, brain extraction and PSa pp decreased significantly by 29% (20% to 39%) and 38% (27% to 51 %), respectively, compared with the saline bolus. In hypercapnia, Pco 2 increased from 39. 1 (39.9 to 39.4) mm Hg to 78.6 (77.3 to 80.3) mm Hg. A subse quent 264% (160% to 322%) increase in CBF did not lead to a significant reduction in extraction, and PSa pp increased significantly by 109% (71 % to 244%). In hy pocapnia, Pco 2 decreased from 39.8 (39.2 to 39.9) mm Hg to 29.0 (27. 1 to 30.8) mm Hg, which reduced CBF by 34% (20% to 46%). This led to a significant 13% (2% to 21 %) increase in the extraction, whereas PSa pp did not change significantly (P = 0.059).
Flumazenil
For flumazenil, fe q was 61 % in 5% human albumin. Brain extraction and PSa pp were unaltered, whether a 20-or 120-IJL bolus was used (n = 7, Mann-Whitney test). No difference between peak and the total extraction was found. Values for CBF, extraction, and PSa pp are pre sented in Table 1 . At the presence of 5% albumin in the bolus injectate, PSa pp decreased significantly by 17% (11 % to 22%) compared with a saline bolus, whereas the extraction did not change significantly. In hypercapnia, Pco 2 increased from 39 . 0 (38 . 3 to 39 . 2) mm Hg to 78.6 (77.0 to 84.0) mm Hg, and CBF increased by 197% (88% to 259%) and PSapp increased significantly by 186% (38% to 538%). In hypocapnia, Peo 2 fell from 39.4 (37.9 to 40. 1) mm Hg to 26.5 (24.9 to 29. 1) mm Hg with a concomitant significant CBF reduction of 27% (16% to 41 %). Extraction and PSapp did not change significantly.
Protein binding
With saline bolus, extraction and PSapp were similar for the two ligands, whereas PSapp was significantly higher for flumazenil than for iomazenil when 5% albu min was present in the bolus.
For iomazenil, fe q was 42% (40%, 44%) and favai l was 62% (49%, 73%), which is a 32% larger favail than fe q . For flumazenil, favail was 27% higher than fe q . The fe q was 61% (59%, 62%), and the favail was 84% (78%, 89%).
As evaluated from Eq. 4, Kd was 525 j.1mollL for iomazenil and 1135 j.1mollL for flumazenil. Table 2 shows the results of best fit simulations and the experimental observations. With the nonequilibrium model simulations, some of the observed effect of chang ing CBF could be explained when a plasma protein ligand dissociation constant (k off ) of 0.05 seconds-I was applied. For the heterogeneity model simulations, normal, log(normal), and exponential distributions of capil lary lengths were applied to the data for iomazenil. All distributions produced effects in the observed direction (favail > fe q , and PSapp increased with CBF), but only a declining exponential distribution provided a good ac cordance between simulated and observed results. When the same distribution then was applied to the flumazenil data, a good accordance with the observed data was found (Table 2 ).
Simulations
DISCUSSION
Validation of cerebral blood flow-related changes
For both ligands, PSapp increased significantly with CBF (Fig. 2) . This is in accordance with the study of Holthoff et al. (199 1) , where KI for [ 11 C]flumazenil in creased with visual activation. Similar phenomena also have been observed previously for flow tracers (Ander sen et aI., 1988), glucose, and amino acids (Hertz and Paulson, 1982; Chen J-L et aI., 1994) .
The double-indicator technique yields global values for brain extraction, whereas the CBF technique mea surements represents CBF values weighted toward gray matter, which theoretically would lead to ' a slight over estimation of PS. Since the rat brain' contains relatively small amounts of white matter, this difference is less crucial. Further, in the calculation of favail, CBF cancels out. Theoretically, blood flow may increase during the intracarotid injection, but it has been demonstrated that bolus sizes up to 100 j.1L do not alter CBF (Hertz et aI., 1984) .
Most authors have interpreted the flow-dependent in crease in brain uptake as capillary recruitment, that is, that the brain under certain circumstances is able to re cruit unperfused capillaries to increase the surface area available for diffusion (Kuschinsky and Paulson, 1992) . Less frequently, it has been considered that capillary het erogeneity may account for this phenomenon (Knudsen et aI., 1991) .
Validation of in vitro and in vivo protein-ligand interaction
The in vitro free fraction of iomazeni1 and flumazenil is comparable with previously published values of 29% to 46% (Gandelman et aI., 1994) and 50% to 60% (Brog den and Goa, 1991), respectively.
The addition of albumin to the injectate is expected to reduce PSapp' Albumin addition, however, lead to a smaller decrease in PSapp than expected from Eq. 3. Theoretically, the difference between fe q and favail may arise from blood contamination of the albumin-free bo lus, since then PSpr o tein-absent would be underestimated (Eq. 3). The difference between fe q and favail is, accord ing to Eq. 4, only explained if protein contamination of the saline bolus increases plasma albumin concentration from zero to 247 j.1mollL in the iomazenil study and 490 f,Lmol/L in the flumazenil study. This seems highly un likely, since with the brain uptake index technique, the upper bound for bolus mixing with blood has been esti mated to be about 5% (Pardridge et aI., 1985) . Our observation is in line with previous studies in the brain where the presence of albumin apparently enhances uptake of protein-bound substances such as tryptophan (Pardridge and Fierer, 1990) , hormones, and drugs (Jones et aI., 1988 ) by 4 to 25 times. Generally, the degree of enhancement increases with extraction and protein binding. = fe q needs to be examined. These are (1) only free ligand in the plasma water can be taken up from by the brain, (2) plasma protein-ligand equilibrium is present at any position along the capillary, (3) cross-sectional cap illary concentration gradients are not present, and (4) the brain can be modeled as a set of identical capillaries (no capillary heterogeneity).
Explanations for unexpected behavior
To explain our findings (i.e., both the difference be tween fe q and favai l and the increase in PS a pp with CBF), the underlying assumptions for the hypothesis that fa vail Violation of the first assumption often has been con sidered responsible when PSa pp increased as albumin is added. Pardridge and Fierer (1990) interpreted it as being caused by in vitro and in vivo differences in the protein ligand dissociation/association. Others have proposed that enhancement is caused by either the existence of an albumin receptor that facilitates ligand uptake from the bound state, by conformational changes of albumin near the endothelial cell surface, or by membrane near pH Values are given in mU(g . min). PSapp' permeability-surface product. With increasing CBF, the free ligand concentration would decrease less during the passage of the capillary.
That is, binding disequilibrium may explain an increase in PSapp found with increasing CBF. As can be seen from Implications for receptor studies (1994) , who also noticed that the distribution volume of raclopride reduced as CBF decreases.
In tissue reference models, a reference region void of receptors is used to estimate nonspecific ligand binding, and the distribution volume of the target area is deter mined relative to the reference region. For this method, underestimation of favai l does not hamper the measure ment, although the CBF dependence of uptake poten tially may lead to differences between the region of in terest and the reference region. This consideration may be particularly relevant in receptor activation studies.
In neuroreceptor studies where the ligand is infused to obtain a steady-state condition, eventual changes in PSapp caused by regional CBF variations between the studies will cancel out. The free fraction of unlabeled ligand then may be calculated as the total blood concen tration times fe q if heterogeneity alone causes the ob served difference between feg and favail' By contrast, if enhancement takes place, the free fraction is underesti mated, whereby the affinity of the studied ligand is over estimated.
APPENDIX Simulating nonequilibrium protein binding
The model of Weisiger et al. (1991) is applicable to the brain if all brain capillaries are assumed to be iden tical, that is, that permeability per unit of surface area (P), capillary surface area (S), diameter, and flow are the same for all capillaries. For each ligand, P was calibrated from the saline injectate data to produce the observed PSpr o tein-absent. This value of P then entered the calcula tions to predict the effect of changing CBF. The follow ing values were used: plasma albumin concentration, 725 fLmollL (5% albumin); K d , 525 fLmollL for iomaze nil and 1135 fLmollL for flumazenil (from Results); S, 70 cm 2 g-I (Gross et al. 1986 Table 2 .
SimUlating capillary heterogeneity
The brain was considered as consisting of n capillar ies, denoted 1,2, .. ,i , .. ,n. All capillaries have the same permeability per surface area (P) and flow rate q = CBF/n. The individual surface areas (S I ,Slo .. ,Si, .. ,Sn) are different because of a distribution of capillary lengths. All capillaries share the same influx concentra tion, A, while having different outflow concentrations, VI'V2' " ,Vi"
, vn' For capillary i, we then have fe q ·PSi
The combined outflow concentration of the organ, V com bined' then can be calculated by 1 ( fe q PS I fe q PS2 fe q PSn )
Vcom bined = A � e--q -+ e--q -+ ..... + e--q -
PSap p calculated from Eq. A2 is then:
( 1 fe q PS I fe q PS2 fe q psn )
PSa pp =-CBF ·In �(e--g-+e--q -+ ..... e --q-
From Eq. A3, it follows that when all capillary lengths are equal (homogeneity), PSapp = fe q . P . (S I + S 2 + .. + Sn), and then PSapp is independent of CBF, and favai l = feg. In contrast, when capillary lengths vary, PSapp < feg . P . (SI + S 2 + .. + Sn). In the latter case, Eq. A3 reveals that PSap p increases with increased CBF and that favai l > fe q· For simulation of capillary length heterogeneity, a spreadsheet based computer program (Lotus 123, Ver sion 2.3, Lotus Development Corporation, Cambridge, MA, U.S.A.) modeling up to 400 classes of different capillary lengths was used. Given a distribution of cap illary lengths, the total number of capillaries per gram of brain was adjusted to achieve a total surface area of 70 cm 2 g-I with a capillary volume of 5 . lO-3 cm 3 g-I (Gross et a!., 1986) . The individual venous outflow con centrations were calculated from Eq. A2, and their weighted average was subsequently used for calculation of E for the whole brain. The PSapp was calculated by Eq. A3. For a given distribution, P was fitted for each ligand to produce the observed PSpr o tein-absent. With this value of P, effects of changing fe g and CBF were calculated. In this way, a combination of a distribution of capillary lengths and a matching value of P that fitted the ioma zenil observations was found and the same distribution was subsequently tested on the flumazenil observed data.
